New bleeding treatment for tiny hearts shows promise
NCT ID NCT04376762
First seen Mar 21, 2026 · Last updated Apr 28, 2026 · Updated 6 times
Summary
This study tested whether a purified clotting medicine (fibrinogen concentrate) works as well as a standard blood product (cryoprecipitate) to control bleeding in infants after heart surgery. Thirty-one children under 2 years old were randomly assigned to receive one of the two treatments. The goal was to see if the concentrate could reduce the need for additional blood transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.